» Articles » PMID: 2349960

Prevention of Myelinolysis in Rats by Dexamethasone or Colchicine

Overview
Journal Am J Nephrol
Publisher Karger
Specialty Nephrology
Date 1990 Jan 1
PMID 2349960
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of the present investigation was to determine whether dexamethasone, an agent known to preserve the blood-brain barrier, and colchicine, an agent that impairs mobilization of macrophages, can prevent demyelinating lesions associated with rapid correction of hyponatremia in the experimental animal. Hyponatremia was induced in rats with Pitressin and water. After 4 days hyponatremic rats received hypertonic saline alone or hypertonic saline plus dexamethasone or colchicine. All of the 9 rats that received only 5% NaCl developed demyelinating disease, while 3 of 6 rats treated with dexamethasone and 5 of 15 rats treated with colchicine showed no CNS abnormality. The results of our investigation might help understand the pathogenetic mechanism of central pontine myelinolysis in humans, a disease attributed to rapid correction of hyponatremia.

Citing Articles

Osmotic Demyelination: From an Oligodendrocyte to an Astrocyte Perspective.

Nicaise C, Marneffe C, Bouchat J, Gilloteaux J Int J Mol Sci. 2019; 20(5).

PMID: 30841618 PMC: 6429405. DOI: 10.3390/ijms20051124.


Central pontine myelinolysis: historical and mechanistic considerations.

Norenberg M Metab Brain Dis. 2010; 25(1):97-106.

PMID: 20182780 DOI: 10.1007/s11011-010-9175-0.


Possible causes of central pontine myelinolysis after liver transplantation.

Yu J, Zheng S, Liang T, Shen Y, Wang W, Ke Q World J Gastroenterol. 2004; 10(17):2540-3.

PMID: 15300900 PMC: 4572157. DOI: 10.3748/wjg.v10.i17.2540.


Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.

Videen J, Michaelis T, Pinto P, Ross B J Clin Invest. 1995; 95(2):788-93.

PMID: 7860762 PMC: 295555. DOI: 10.1172/JCI117728.


Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances: II.

Trachtman H Pediatr Nephrol. 1992; 6(1):104-12.

PMID: 1536729 DOI: 10.1007/BF00856852.